Stocks and InvestingStocks and Investing
Tue, September 21, 2021
Mon, September 20, 2021
Fri, September 17, 2021
Thu, September 16, 2021
Wed, September 15, 2021
Tue, September 14, 2021
Mon, September 13, 2021

Jonathan Chang Maintained (ADAP) at Hold with Increased Target to $7 on, Sep 13th, 2021


Published on 2024-10-27 17:53:34 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Hold with Increased Target from $6 to $7 on, Sep 13th, 2021.

Jonathan has made no other calls on ADAP in the last 4 months.



There is 1 other peer that has a rating on ADAP. Out of the 1 peers that are also analyzing ADAP, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan


  • Peter Lawson of "Barclays" Initiated at Sell and Held Target at $4 on, Friday, May 28th, 2021